Boston Scientific Cash on Hand 2010-2024 | BSX
Boston Scientific cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Boston Scientific cash on hand for the quarter ending March 31, 2024 was $2.329B, a 308.6% increase year-over-year.
- Boston Scientific cash on hand for 2023 was $0.865B, a 6.79% decline from 2022.
- Boston Scientific cash on hand for 2022 was $0.928B, a 51.79% decline from 2021.
- Boston Scientific cash on hand for 2021 was $1.925B, a 11.01% increase from 2020.
| Boston Scientific Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $865 |
| 2022 | $928 |
| 2021 | $1,925 |
| 2020 | $1,734 |
| 2019 | $217 |
| 2018 | $146 |
| 2017 | $188 |
| 2016 | $196 |
| 2015 | $319 |
| 2014 | $587 |
| 2013 | $217 |
| 2012 | $207 |
| 2011 | $267 |
| 2010 | $213 |
| 2009 | $864 |
| Boston Scientific Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-03-31 | $2,329 |
| 2023-12-31 | $865 |
| 2023-09-30 | $952 |
| 2023-06-30 | $426 |
| 2023-03-31 | $570 |
| 2022-12-31 | $928 |
| 2022-09-30 | $338 |
| 2022-06-30 | $276 |
| 2022-03-31 | $325 |
| 2021-12-31 | $1,925 |
| 2021-09-30 | $1,947 |
| 2021-06-30 | $2,675 |
| 2021-03-31 | $2,016 |
| 2020-12-31 | $1,734 |
| 2020-09-30 | $2,022 |
| 2020-06-30 | $1,724 |
| 2020-03-31 | $370 |
| 2019-12-31 | $217 |
| 2019-09-30 | $277 |
| 2019-06-30 | $123 |
| 2019-03-31 | $139 |
| 2018-12-31 | $146 |
| 2018-09-30 | $168 |
| 2018-06-30 | $208 |
| 2018-03-31 | $287 |
| 2017-12-31 | $188 |
| 2017-09-30 | $210 |
| 2017-06-30 | $195 |
| 2017-03-31 | $156 |
| 2016-12-31 | $196 |
| 2016-09-30 | $237 |
| 2016-06-30 | $438 |
| 2016-03-31 | $338 |
| 2015-12-31 | $319 |
| 2015-09-30 | $350 |
| 2015-06-30 | $903 |
| 2015-03-31 | $242 |
| 2014-12-31 | $587 |
| 2014-09-30 | $246 |
| 2014-06-30 | $357 |
| 2014-03-31 | $191 |
| 2013-12-31 | $217 |
| 2013-09-30 | $571 |
| 2013-06-30 | $530 |
| 2013-03-31 | $268 |
| 2012-12-31 | $207 |
| 2012-09-30 | $352 |
| 2012-06-30 | $371 |
| 2012-03-31 | $284 |
| 2011-12-31 | $267 |
| 2011-09-30 | $276 |
| 2011-06-30 | $154 |
| 2011-03-31 | $595 |
| 2010-12-31 | $213 |
| 2010-09-30 | $624 |
| 2010-06-30 | $811 |
| 2010-03-31 | $519 |
| 2009-12-31 | $864 |
| 2009-09-30 | $1,381 |
| 2009-06-30 | $1,194 |
| 2009-03-31 | $897 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $112.306B | $14.240B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.530B | 23.51 |
| Stryker (SYK) | United States | $127.352B | 30.50 |
| Medtronic (MDT) | Ireland | $99.209B | 14.85 |
| EssilorLuxottica (ESLOY) | France | $98.424B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.079B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.036B | 27.77 |
| ResMed (RMD) | United States | $27.817B | 26.12 |
| Terumo (TRUMY) | Japan | $24.149B | 34.10 |
| Koninklijke Philips (PHG) | Netherlands | $22.914B | 18.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.863B | 13.97 |
| Baxter (BAX) | United States | $16.740B | 11.90 |
| Insulet (PODD) | United States | $13.811B | 61.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.789B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.686B | 36.15 |
| Bio-Rad Laboratories (BIO) | United States | $7.632B | 24.96 |
| Lantheus Holdings (LNTH) | United States | $5.441B | 13.56 |
| Haemonetics (HAE) | United States | $4.232B | 20.87 |
| GN Store Nord (GNNDY) | Denmark | $4.129B | 23.18 |
| Perrigo (PRGO) | Ireland | $3.543B | 10.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.408B | 16.22 |
| Neogen (NEOG) | United States | $3.277B | 31.52 |
| ICU Medical (ICUI) | United States | $2.864B | 25.27 |
| TG Therapeutics (TGTX) | United States | $2.830B | 79.61 |
| Envista Holdings (NVST) | United States | $2.808B | 11.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.387B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.363B | 46.25 |
| QuidelOrtho (QDEL) | United States | $2.100B | 11.66 |
| LeMaitre Vascular (LMAT) | United States | $1.822B | 53.41 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.723B | 0.00 |
| Warby Parker (WRBY) | United States | $1.589B | 0.00 |
| InMode (INMD) | Israel | $1.462B | 7.77 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
| Verano Holdings (VRNOF) | United States | $1.228B | 0.00 |
| AtriCure (ATRC) | United States | $1.065B | 0.00 |
| Owens & Minor (OMI) | United States | $1.013B | 8.83 |
| National Vision Holdings (EYE) | United States | $0.980B | 31.20 |
| BioLife Solutions (BLFS) | United States | $0.932B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.40 |
| PetIQ (PETQ) | United States | $0.672B | 21.72 |
| Evolus (EOLS) | United States | $0.667B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.596B | 14.02 |
| Valneva SE (VALN) | France | $0.505B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.19 |
| Quanterix (QTRX) | United States | $0.487B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.477B | 0.00 |
| Biote (BTMD) | United States | $0.475B | 10.93 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.376B | 0.00 |
| Cerus (CERS) | United States | $0.314B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.302B | 9.71 |
| Zynex (ZYXI) | United States | $0.288B | 39.44 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.233B | 14.69 |
| Omeros (OMER) | United States | $0.223B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.213B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 21.96 |
| Capricor Therapeutics (CAPR) | United States | $0.151B | 0.00 |
| Veru (VERU) | United States | $0.140B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.19 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.093B | 15.77 |
| Cellectar Biosciences (CLRB) | United States | $0.085B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.43 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.52 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |